OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Anti prostate cancer therapy: Aptamer-functionalized, curcumin and cabazitaxel co-delivered, tumor targeted lipid-polymer hybrid nanoparticles
Yougan Chen, Yuanyuan Deng, Chenyao Zhu, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 127, pp. 110181-110181
Open Access | Times Cited: 102
Yougan Chen, Yuanyuan Deng, Chenyao Zhu, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 127, pp. 110181-110181
Open Access | Times Cited: 102
Showing 26-50 of 102 citing articles:
Prostate cancer: Therapeutic prospect with herbal medicine
Suvranil Ghosh, Joyita Hazra, Koustav Pal, et al.
Current Research in Pharmacology and Drug Discovery (2021) Vol. 2, pp. 100034-100034
Open Access | Times Cited: 33
Suvranil Ghosh, Joyita Hazra, Koustav Pal, et al.
Current Research in Pharmacology and Drug Discovery (2021) Vol. 2, pp. 100034-100034
Open Access | Times Cited: 33
Current development of cabazitaxel drug delivery systems
Boyang Sun, Jonathan F. Lovell, Yumiao Zhang
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2022) Vol. 15, Iss. 2
Closed Access | Times Cited: 27
Boyang Sun, Jonathan F. Lovell, Yumiao Zhang
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2022) Vol. 15, Iss. 2
Closed Access | Times Cited: 27
Biomolecule-functionalized nanoformulations for prostate cancer theranostics
Pranav Tiwari, Partha Laskar, Meena Jaggi, et al.
Journal of Advanced Research (2022) Vol. 51, pp. 197-217
Open Access | Times Cited: 26
Pranav Tiwari, Partha Laskar, Meena Jaggi, et al.
Journal of Advanced Research (2022) Vol. 51, pp. 197-217
Open Access | Times Cited: 26
Cell-derived artificial nanovesicle as a drug delivery system for malignant melanoma treatment
Ying-Yi Lin, Chung‐Yi Chen, Dik‐Lung Ma, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 147, pp. 112586-112586
Open Access | Times Cited: 25
Ying-Yi Lin, Chung‐Yi Chen, Dik‐Lung Ma, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 147, pp. 112586-112586
Open Access | Times Cited: 25
Exosomes: Insights and therapeutic applications in cancer
Anita Raj Panigrahi, Srinivas Lankalapalli, Jagadeesh Panda
Translational Oncology (2022) Vol. 21, pp. 101439-101439
Open Access | Times Cited: 25
Anita Raj Panigrahi, Srinivas Lankalapalli, Jagadeesh Panda
Translational Oncology (2022) Vol. 21, pp. 101439-101439
Open Access | Times Cited: 25
Aptamers in cancer therapy: problems and new breakthroughs
Baijiang Jin, Zhukang Guo, Zhu Chen, et al.
Journal of Materials Chemistry B (2023) Vol. 11, Iss. 8, pp. 1609-1627
Closed Access | Times Cited: 16
Baijiang Jin, Zhukang Guo, Zhu Chen, et al.
Journal of Materials Chemistry B (2023) Vol. 11, Iss. 8, pp. 1609-1627
Closed Access | Times Cited: 16
Cabazitaxel-nano delivery systems as a cutting-edge for cancer therapy
Mehrab Pourmadadi, Amirhossein Ghaemi, Meysam Shaghaghi, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 82, pp. 104338-104338
Closed Access | Times Cited: 14
Mehrab Pourmadadi, Amirhossein Ghaemi, Meysam Shaghaghi, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 82, pp. 104338-104338
Closed Access | Times Cited: 14
Synergistic combination therapy of lung cancer using lipid-layered cisplatin and oridonin co-encapsulated nanoparticles
Xinglong Fan, Tian Wang, Zhongyi Ji, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 141, pp. 111830-111830
Open Access | Times Cited: 29
Xinglong Fan, Tian Wang, Zhongyi Ji, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 141, pp. 111830-111830
Open Access | Times Cited: 29
Recent advances in polymeric core–shell nanocarriers for targeted delivery of chemotherapeutic drugs
Xiuru Yang, Yan Xie
International Journal of Pharmaceutics (2021) Vol. 608, pp. 121094-121094
Closed Access | Times Cited: 29
Xiuru Yang, Yan Xie
International Journal of Pharmaceutics (2021) Vol. 608, pp. 121094-121094
Closed Access | Times Cited: 29
Development of fully bio-based pectin/curcumin@bio-MOF-11 for colon specific drug delivery
Hafezeh Nabipour, Yuan Hu
Chemical Papers (2022) Vol. 76, Iss. 5, pp. 2969-2979
Closed Access | Times Cited: 20
Hafezeh Nabipour, Yuan Hu
Chemical Papers (2022) Vol. 76, Iss. 5, pp. 2969-2979
Closed Access | Times Cited: 20
Aptamers against cancer drug resistance: Small fighters switching tactics in the face of defeat
Mehdi Sanati, Amir R. Afshari, Seyed Sajad Ahmadi, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1869, Iss. 6, pp. 166720-166720
Closed Access | Times Cited: 12
Mehdi Sanati, Amir R. Afshari, Seyed Sajad Ahmadi, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1869, Iss. 6, pp. 166720-166720
Closed Access | Times Cited: 12
In vitro study of a new theranostic smart niosomal nanostructure for direct delivery of docetaxel via anti-PSMA aptamer
Negar Nasri, Shaghayegh Saharkhiz, Ghasem Dini, et al.
Heliyon (2024) Vol. 10, Iss. 17, pp. e37341-e37341
Open Access | Times Cited: 4
Negar Nasri, Shaghayegh Saharkhiz, Ghasem Dini, et al.
Heliyon (2024) Vol. 10, Iss. 17, pp. e37341-e37341
Open Access | Times Cited: 4
Therapeutic Potential of Plant- and Marine-Derived Bioactive Compounds in Prostate Cancer: Mechanistic Insights and Translational Applications
Arif Jamal Siddiqui, Mohd Adnan, Juhi Saxena, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 286-286
Open Access
Arif Jamal Siddiqui, Mohd Adnan, Juhi Saxena, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 286-286
Open Access
Medicinal plants from the Mediterranean basin as a source of natural antiprostate cancer agents
Rosa Tundis
Elsevier eBooks (2025), pp. 257-290
Closed Access
Rosa Tundis
Elsevier eBooks (2025), pp. 257-290
Closed Access
Anticancer activity of curcumin-loaded nanocarriers: A focus on combined therapeutic modalities
Fatih Şentürk, Huriye Yasar, Anzel Bahadır, et al.
Studies in natural products chemistry (2025), pp. 1-39
Closed Access
Fatih Şentürk, Huriye Yasar, Anzel Bahadır, et al.
Studies in natural products chemistry (2025), pp. 1-39
Closed Access
Functionalized Nanomaterials in Cancer Treatment: A Review
Óscar Gutiérrez Coronado, Cuauhtémoc Sandoval‐Salazar, José Luis Muñoz‐Carrillo, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2633-2633
Open Access
Óscar Gutiérrez Coronado, Cuauhtémoc Sandoval‐Salazar, José Luis Muñoz‐Carrillo, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2633-2633
Open Access
Oral Bioavailability Enhancement of Anti-Cancer Drugs Through Lipid Polymer Hybrid Nanoparticles
Saud Almawash
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 381-381
Open Access
Saud Almawash
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 381-381
Open Access
Terbinafine for prostate cancer: development of coated zein nanospheres for ameliorated pro-apoptosis in PC3 cells
Majid Mohammad Al-Sawahli, Yasmin A. El-Feky, Ahmed J. Mohammed, et al.
Nanomedicine (2025), pp. 1-17
Closed Access
Majid Mohammad Al-Sawahli, Yasmin A. El-Feky, Ahmed J. Mohammed, et al.
Nanomedicine (2025), pp. 1-17
Closed Access
Polymer/Lipid Core-Shell Nanoconstructs for Cancer Theragnostic
Viola Colaco, Anoushka Mukharya, Amrita Arup Roy, et al.
(2025), pp. 241-280
Closed Access
Viola Colaco, Anoushka Mukharya, Amrita Arup Roy, et al.
(2025), pp. 241-280
Closed Access
Surface Functionalized Lipid Nanoparticles in Promoting Therapeutic Outcomes: An Insight View of the Dynamic Drug Delivery System
Namish Manchanda, Harish Vishkarma, Muskan Goyal, et al.
Current Drug Targets (2024) Vol. 25, Iss. 4, pp. 278-300
Closed Access | Times Cited: 3
Namish Manchanda, Harish Vishkarma, Muskan Goyal, et al.
Current Drug Targets (2024) Vol. 25, Iss. 4, pp. 278-300
Closed Access | Times Cited: 3
Aptamers for the Delivery of Plant-Based Compounds: A Review
Joana Gamboa, Pedro Lourenço, Carla Cruz, et al.
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 541-541
Open Access | Times Cited: 3
Joana Gamboa, Pedro Lourenço, Carla Cruz, et al.
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 541-541
Open Access | Times Cited: 3
Nanomedicine for Prostate Cancer Treatment
Ahmad Mobed, Zinat Sargazi, Reza Kheradmand, et al.
BioNanoScience (2024) Vol. 14, Iss. 4, pp. 4280-4297
Closed Access | Times Cited: 3
Ahmad Mobed, Zinat Sargazi, Reza Kheradmand, et al.
BioNanoScience (2024) Vol. 14, Iss. 4, pp. 4280-4297
Closed Access | Times Cited: 3
Aptamer-mediated therapeutic strategies provide a potential approach for cancer
Bingshuo Yan, Yuting Li, Shiming He
International Immunopharmacology (2024) Vol. 136, pp. 112356-112356
Closed Access | Times Cited: 3
Bingshuo Yan, Yuting Li, Shiming He
International Immunopharmacology (2024) Vol. 136, pp. 112356-112356
Closed Access | Times Cited: 3
Lipid polymer hybrid nanoparticles against lung cancer and their application as inhalable formulation
Seyedeh Negin Kassaee, Derek J. Richard, Godwin A. Ayoko, et al.
Nanomedicine (2024) Vol. 19, Iss. 25, pp. 2113-2133
Closed Access | Times Cited: 3
Seyedeh Negin Kassaee, Derek J. Richard, Godwin A. Ayoko, et al.
Nanomedicine (2024) Vol. 19, Iss. 25, pp. 2113-2133
Closed Access | Times Cited: 3
Comprehensive Review on the Development of Phytonanomedicines for Cancer Treatment
Donald A. Fernandes
Deleted Journal (2025)
Closed Access
Donald A. Fernandes
Deleted Journal (2025)
Closed Access
